MedTrace Logo

Velacur by Sonic Incytes for Portal Hypertension

NCT04576897 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2023-09-05

Study results available
· View outcomes & findings →

Summary

This is a cross sectional study that evaluates the relationship between LSM (liver stiffness measurement) by Liver Incytes in patients with cACLD (compensated advanced chronic liver disease) and manifestations of portal hypertension.

Conditions

  • Portal Hypertension
  • Chronic Advanced Liver Disease

Interventions

DIAGNOSTIC_TEST

Velacur

Ultrasound elasticity imaging

Sponsors & Collaborators

  • Sonic Incytes

    collaborator INDUSTRY

  • Indiana University

    lead OTHER

Principal Investigators

  • Samer Gawrieh, MD · Indiana University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-04-19
Completion
2022-04-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04576897 on ClinicalTrials.gov